Forward P/S Multiple: OrthoPediatrics Corp (KIDS)
Despite pressure from general medtech behemoths, the forward P/S of OrthoPediatrics Corp. (KIDS) demonstrates resilient dynamics, where the 3.20 mark characterizes this parameter. Stability is ensured by the company's own precision assembly plants in the US. Meanwhile, financial stability is based on its monopoly status within the niche and the demand for specialized fixators in surgical centers.
Summary analytical data breakdowns for orthopediatrics.com (KIDS)
- market price and analyst price targets:
- company stock exchange capitalization indicators:
- issuer book value statistics:
- debt and liquidity data:
Total Debt to Capital OrthoPediatrics Corp.|KIDS - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital OrthoPediatrics|KIDS - Company Aggregate Debts|Debt to Book Capitalization Ratio OrthoPediatrics Corp|KIDS - Company Long-Term Debt|Company Current Liabilities OrthoPediatrics|Quick Ratio orthopediatrics.com
- financial results and valuation multiples details:
KIDS - Company Net Income|Expected Profit OrthoPediatrics Corp.|KIDS - Market Cap to Net Income Ratio|Projected Price to Earnings OrthoPediatrics|KIDS - PEG Multiple|EV/EBITDA Multiple OrthoPediatrics Corp|KIDS - Operating income before deduction of amortization|Earnings per share for the last twelve months OrthoPediatrics|KIDS - Earnings per one share for the last 12 months|Year-over-year earnings per share growth for the last twelve months orthopediatrics.com|KIDS - Net earnings per share growth this year|Earnings growth forecast for next year OrthoPediatrics Corp.
- sales and revenue indicators:
Fundamental company analysis:KIDS (OrthoPediatrics Inc.)
The scaling of OrthoPediatrics Corp. (KIDS) depends on implant adoption rates and FDA certification. The forward P/S ratio compares the current market value of the business with expected sales volume, reflecting the valuation's sensitivity to revenue forecasts. This metric measures the premium an investor is willing to pay for future cash flows amid inflation. The dynamics of the forward P/S allow for the timely identification of stagnating demand for fixation systems.
Who OrthoPediatrics Corp. competes with
Price-to-Projected Revenue Ratio Boston Scientific Corporation BSX|EW - Forward Price-to-Revenue Multiple|ResMed Corp - Forward P/S Multiple|Market Cap to Future Revenue Ratio Insulet Inc.|ZBH: Forward P/S Multiple|Market Cap to Projected Revenue COO|ALGN (Align Technology) - Forward P/S Multiple|Globus Medical Inc (GMED) - Market Cap to Expected Sales Ratio|Forward P/S Multiple TMDX|Forward Price-to-Revenue Multiple Alphatec Corp ATEC|Forward P/S Multiple AORT (Artivion, Inc.)|Forward P/S Multiple enovis.com ENOV|IART - Price-to-Projected Revenue Ratio|ESTA: Price-to-Projected Revenue Ratio|BBNX (Beta Bionics Corp) - Forward Price-to-Revenue Multiple|IRADIMED Inc. - Forward Price to Sales|EMBC (Embecta Corp.) - Forward P/S Multiple|Market Cap to Future Revenue Ratio tandemdiabetes.com TNDM|Price-to-Projected Revenue Ratio Axogen (AXGN)|SI-BONE Inc (SIBN) - Projected Price to Revenue|Orthofix International - Forward Price-to-Revenue Multiple|Forward P/S Multiple Bioventus Global BVS|Treace Medical Concepts - Forward P/S Multiple|Market Cap to Expected Sales Ratio blade.com SRTA|Carlsmed (CARL) - Price-to-Projected Revenue Ratio|Future Price to Revenue RXST (RxSight Inc)|Price-to-Projected Revenue Ratio ClearPoint Neuro Inc.|Forward Price-to-Revenue Multiple Stereotaxis Corporation (STXS)|Forward P/S Multiple STIM|SGHT - Market Cap to Future Revenue Ratio|Price-to-Projected Revenue Ratio Orchestra BioMed, Inc. OBIO|ANIK: Market Cap to Projected Revenue|NSPR: Forward Price-to-Revenue Multiple|Jin Medical International - Price to Expected Revenue Ratio|vivani.com (VANI) - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Xtant Medical (XTNT)|Price-to-Projected Revenue Ratio NeuroOne Medical Technologies Corporation|MODD: Forward Price to Sales|Forward Price-to-Revenue Multiple MYO (Myomo, Inc)|Price to Expected Revenue Ratio COCH|Forward P/S Multiple VVOS (Vivos Therapeutics)|Forward Price to Sales NVNO|SINT - Price-to-Projected Revenue Ratio|Market Cap to Future Revenue Ratio Tenon Medical Inc.|ReWalk Robotics Ltd (LFWD) - Price-to-Projected Revenue Ratio|Future Price to Revenue AMIX (Autonomix Medical)|IVF (INVO Fertility Inc) - Forward P/S Multiple|Market Cap to Future Revenue Ratio bonebiologics.com BBLG|Forward P/S Multiple AXNX|BIOLASE Inc. - Market Cap to Projected Revenue|Forward P/S Multiple DYNT (Dynatronics)|Market Cap to Expected Sales Ratio Paragon 28 Inc. (FNA)|INVO Bio - Forward P/S Multiple
